Page last updated: 2024-08-23

etoposide and Microsatellite Instability

etoposide has been researched along with Microsatellite Instability in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Di Sabatino, A; Furlan, D; La Rosa, S; Martino, M; Neri, G; Perfetti, V; Sessa, F; Solcia, E; Vanoli, A; Viglio, A	1

Other Studies

1 other study(ies) available for etoposide and Microsatellite Instability

Article	Year
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift. Endocrine pathology, 2020, Volume: 31, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; DNA Mismatch Repair; Etoposide; Humans; Male; Microsatellite Instability; Middle Aged; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Remission Induction	2020

Article

Year

Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.

Endocrine pathology, 2020, Volume: 31, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; DNA Mismatch Repair; Etoposide; Humans; Male; Microsatellite Instability; Middle Aged; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Remission Induction

2020